Background Although several transcriptome-wide association studies (TWASs) have been
performed to identify genes associated with overall breast cancer (BC) risk, only a few TWAS …

Background Breast cancer (BC) has the highest cancer incidence and mortality in women
worldwide. Observational epidemiological studies suggest a positive association between …

Background There is increasing evidence that breast cancer is a heterogeneous disease
presented by different phenotypes and that white women have a higher breast cancer …

Purpose: Consensus is lacking regarding the androgen receptor (AR) as a prognostic
marker in breast cancer. The objectives of this study were to comprehensively review the …

Introduction Breast cancer is a heterogeneous disease and may be characterized on the
basis of whether estrogen receptors (ER) are expressed in the tumour cells. ER status of …

Breast cancer is a serious worldwide public health problem and is currently the most
common cancer overall. Its endocrine therapy is related to the expression of the steroid …

Background Male breast cancer (MBC) is a rare disease, accounting for< 1% of all male
carcinomas. Lack of prospective data, the current therapy for MBC is based on retrospective …

Background Estrogens are known to regulate the proliferation of breast cancer cells and to
modify their phenotypic properties. Identification of estrogen-regulated genes in human …

Background Models that predict the risk of estrogen receptor (ER)-positive breast cancers
may improve our ability to target chemoprevention. We investigated the contributions of sex …

For newly diagnosed breast cancer, estrogen receptor status (ERS) is a key molecular
marker used for prognosis and treatment decisions. During clinical management, ERS is …